Skip to main content
logo
Aperam S.A. (LUX:APAM)
Luxembourg flag Luxembourg · Delayed Price · Currency is EUR
26.72
-0.44 (-1.62%)
At close: Jul 29, 2025

Marinus Pharmaceuticals Revenue

Aperam had revenue of 1.65B EUR in the quarter ending June 30, 2025, with 1.22% growth. This brings the company's revenue in the last twelve months to 6.28B, down -0.46% year-over-year. In the year 2024, Aperam had annual revenue of 6.26B, down -5.11%.

Revenue (ttm)
6.28B
Revenue Growth
-0.46%
P/S Ratio
0.31
Revenue / Employee
521.03K
Employees
12,007
Market Cap
1.92B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20246.26B-337.00M-5.11%
Dec 31, 20236.59B-1.56B-19.18%
Dec 31, 20228.16B3.05B59.86%
Dec 31, 20215.10B1.48B40.78%
Dec 31, 20203.62B-616.00M-14.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Reinet Investments S.C.A.798.00M
CPI FIM167.35M
Luxempart50.29M
Socfinasia186.43M
Socfinaf591.38M
Velcan Holdings2.95M
GP Investments-8.48M
Revenue Rankings

Aperam News

More News